🇺🇸 FDA
Patent

US 9018162

Methods for rapidly treating severe hypoglycemia

granted A61KA61K38/26A61K9/0019

Quick answer

US patent 9018162 (Methods for rapidly treating severe hypoglycemia) held by XERIS PHARMACEUTICALS, INC. expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
XERIS PHARMACEUTICALS, INC.
Grant date
Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/26, A61K9/0019, A61K9/19, A61P